Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Ileus: later-stage trial registry

A small indexed set (6 trials) with no open enrollment listed right now.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

Jump to phase mix → How counts are built

6 US clinical trials · none currently recruiting · #2,866 of 28,707 conditions by registered trial count

Ileus: 6 US clinical trials tracked, none currently recruiting.

Ileus is the subject of 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 4 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), running 3 of these trials.

Enrollment posture brief

Registry condition ileus

OPEN 0 | RECR 0% | LATE 4 | EARLY 0 | RANK #2866 | SPON 3

Volume-matched condition peers

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Ileus (this)0%
Open-enrollment share among volume-matched conditions near Ileus

Ileus has no open enrollment in this registry pull (6 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Ileus on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Ileus is recruiting below its size-band peers.

    0 of 6 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Ileus research.

    Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) accounts for 3 of 6 trials (50%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Typical Ileus enrolment sits around 451 participants.

    Median target enrolment is 451 among the 6 trials that report a genuine target (sentinel values excluded). 1 of those (16.7%) plan for fewer than 100 participants.

  4. Ileus research is mostly interventional.

    6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 34

Phase Distribution

PhaseTrial count
Phase 3 4

Top Sponsors

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 3 trials
Aultman Health Foundation 1 trials
Bausch Health Americas 1 trials
Washington University School of Medicine 1 trials

Named interventions

Most-linked intervention names on Ileus records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Alvimopan Drug
3 trials
Placebo Drug
2 trials
alvimopan Drug
1 trials
Standard Post-Op Care Other
1 trials
chewing gum - Extra Winterfresh Other
1 trials
MOA-728 Drug
1 trials

US sites by state

Facility locations filed on Ileus trials. A trial with sites in several states counts in each.

Pennsylvania 3 trials
Ohio 1 trials
Missouri 1 trials
Florida 1 trials
Colorado 1 trials
California 1 trials
Arkansas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Ileus page

6 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ileus condition card totals 6 registered trials; most-linked intervention Alvimopan; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.